4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000118
Chief Medical Officer sold 2,170 shares at $27.09 ($58,785)
- Chief Medical Officer acquired 2,170 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-08-10 | Option exercise 10b5-1 | +2,170 | $16.00 | $34,720 | 53,554 | D |
| Rodman David Malcom Chief Medical Officer | 2026-08-10 | Sale 10b5-1 | −2,170 | $27.09 | $58,785 | 51,384 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-08-10 | Option exercise · Stock Option 10b5-1 | −2,170 | 13,024 | D | ||
| Open-market sales · 2,170 sh · avg $27.09 · $58,785 | |||||||
Loading xslF345X06/wk-form4_1786577585.xml…